Sidley represented Incyte on the deal.Incyte (NASDAQ:INCY) announced its agreement to acquire Villaris Therapeutics, a biopharmaceutical company focused on the development of novel antibody therapeutics. The company’s…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
